The enhancing effect of a triethanolamine-ethanol-isopropyl myristate mixed system on the skin permeation of acidic drugs

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 10, 2002, Pages 1339-1344

  Fang, Liang ^a   Kobayashi, Yoichi ^b   Numajiri, Sachihiko ^a   Kobayashi, Daisuke ^a   Sugibayashi, Kenji ^a   Morimoto, Yasunori ^a  

^a JOSAI UNIVERSITY   (Japan)

^b Toko Pharmaceutical Ind Co Ltd   (Japan)

Author keywords

Acidic drug; Ethanol; Ion pair; Isopropyl myristate; Lipophilic multiconponent system; Triethanolamine

Indexed keywords

ALCOHOL; AMINE; CARBOXYL GROUP; ISOSORBIDE DINITRATE; MEFENAMIC ACID; MYRISTIC ACID ISOPROPYL ESTER; TRIETHANOLAMINE; DRUG; ETHANOLAMINE DERIVATIVE; MYRISTIC ACID DERIVATIVE;

ACIDITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EXCISION; IN VITRO STUDY; MALE; NONHUMAN; RAT; RAT STRAIN; SKIN PERMEABILITY; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; PERMEABILITY; PH; PHYSIOLOGY; SKIN ABSORPTION; SOLUTION AND SOLUBILITY;

ANIMALS; DRUG SYNERGISM; ETHANOL; ETHANOLAMINES; HYDROGEN-ION CONCENTRATION; MALE; MYRISTATES; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; PHARMACEUTICAL SOLUTIONS; RATS; SKIN ABSORPTION;

EID: 0036781258     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.1339     Document Type: Article

References (27)

1. Samir M., Pharm. Res., 17, 1354-1359 (2000).
2. Charles S. A., Bozena B. M., PSTT., 3, 36-41 (2000).
3. Barrie C. F., Timothy M. M., J. Pharm. Sci., 88, 955-958 (1999).
4. Goldberg-Cettina M., Liu P., Nigtingale J., Kurihara-Bergstrom T., Int. J. Pharmaceut., 114, 237-245 (1995).
5. Hori M., Satoh S., Maibach H. I., "Percutaneous Absorption," ed. by Bronaugh R. L., Maibach H. I., Marcel Dekker. New York, 1989, pp. 197-211.
6. Sudhir R. G., Li L. L., Kim K. H., Int. J. Pharmaceut., 192, 159-172 (1999).
7. Morimoto Y., Sugibayashi K., Kobayasbi D., Shoji H., Yamazaki J., Kimura M., Int. J. Pharmaceut., 91, 9-14 (1993).
8. Kobayashi D., Matsuzawa T., Sugibayashi, K., Morimoto Y., Kobayashi M., Kimura M., Biol. Pharm. Bull., 16, 254-258 (1993).
9. Sugibayashi K., Kobayashi D., Nakagaki E., Hatanaka T., Inouue N., Kusumi S., Kobayashi M., Kimura M., Morimoto Y., Int. J. Pharmaceut.. 113, 189-197 (1995).
10. Nakamura H., Pongpaibul Y., Hayashi T., Sugibayashi K., Morimoto Y., Int. J. Pharmaceut., 141, 71-80 (1996).
11. Kobayashi Y., Nakamura H., Sugibayashi K., Morimoto Y., Int. J. Pharmaceut., 156, 153-162 (1997).
12. Nakamura H., Kobayashi Y., Sugibayashi K., Morimoto Y., Drug Del. Sys., 12, 101-106 (1997).
13. Moffat A. C., Jackson C. V., Moss M. S., Widdop B., "Phamaceuticals, Body Fluids and Post-Mortem Material," ed. by The Pharmaceutical Press, Second ed., London, 1986, pp. 533-534.
14. Okumura M., Sugibayashi K., Ogawa K., Morimoto Y., Chem. Pharm. Bull., 37, 1404-1406 (1989).
15. Hirai T., Matsumoto S., Kishi I., J. Chromatogr. B., 692, 375-388 (1997).
16. Dawodu O. F., Meisen A., J. Chromatogr., 629, 297-307 (1993).
17. "Handbook of Pharmaceutical Excipients," American Pharmaceutical Assosiation and The Pharmaceutical Society of Great Britain, 1986, pp. 334-335.
18. Knaak J. B., Leung H. W., Busch Stott W. T. J., Bilsky J., Rev. Environ. Contam. Toxicol., 149, 1-86 (1997).
19. Müller-Decker K., Heinzelmann T., Fürstenberger G., Kecskes A., Lehmann W.-D., Marks F., Toxicol. Appl. Pharmacol., 153, 59-67 (1998).
20. World health organization, "IAAC Monographs on the Evaluation of Carcinogenic Risks to Humans," Vol. 77, Lyon, 2000, pp. 381-401.
21. Cooper E. R., Merritt E. W., Smith R. L., J. Pharm. Sci., 74, 688-690 (1985).
22. Harada S., Takahashi Y., Nakagawa H., Yamashita F., Hashida M., Biol. Pharm. Bull., 23, 1224-1228 (2000).
23. Jin Y., Toeda C., Kawaguchi T., Seki T., Juni K., Drug Dev. Ind. Pharm., 22, 653-658 (1996).
24. Lee Y. L., Chiang C. H., Chen J. L., Drug Dev. Ind. Pharm., 20, 2965-2976 (1994).
25. Inoue K., Ogawa K., Suzuki Y., Okada J., Kusai A., Ikeda M., Nishimura K., Drug Dev. Ind. Pharm., 26, 45-53 (2000).
26. Roberts M. S., Walters K. A., "Dermal Absorption and Toxicity Assessment." ed. by Robert M. S., Walters K. A., Marcel Dekker, New York, 1998, pp. 1-42.
27. Blank I. H., J. Invest. Dermatol., 43, 415-420 (1964).